Keith Katkin, Director at Emergent BioSolutions Inc. (EBS), sold 7,844 shares at $6.30 ($49K) on 2025-05-23, disclosed to the SEC on 2025-05-28.
Scheduled sale ($49k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |
| UROV | SELL | 2019-12-11 | $1.5M | — | Filing → |